Domov › Rakovina prostaty › Maryland › Baltimore
Klinické štúdie Rakovina prostaty v meste Baltimore, MD
43 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v meste Baltimore a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Prebieha náborFáza 3
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie · 9 míľ odtiaľ
- a 1 ďalších
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- a 2 ďalších
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 2
- Johns Hopkins University, Baltimore
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
Prebieha náborObservačná štúdia
- Chesapeake Urology Associates, Towson · 8 míľ odtiaľ
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Prebieha náborFáza 1
- University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Prebieha náborFáza 3
- Baltimore Veterans Affairs Medical Center ( Site 0069), Baltimore
- Greenebaum Comprehensive Cancer Center ( Site 0049), Baltimore
- Chesapeake Urology ( Site 0009), Towson · 8 míľ odtiaľ
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Prebieha náborFáza 3
- University of Maryland Greenebaum Cancer Center, Baltimore
- Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center, Baltimore
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Prebieha náborFáza 3
- Research Site, Towson · 8 míľ odtiaľ
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Prebieha náborFáza 3
- Greenebaum Comprehensive Cancer Center ( Site 0021), Baltimore
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
Prebieha náborObservačná štúdia
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Prebieha náborFáza 2
- Chesapeake Urology Research Associates, Towson · 8 míľ odtiaľ
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Prebieha nábor
- Anne Arundel Urology, Annapolis · 22 míľ odtiaľ
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prebieha náborFáza 3
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Veterans Administration Medical Center-Baltimore, Baltimore
- a 4 ďalších
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
Prebieha nábor
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
Prebieha nábor
- Johns Hopkins Hospital, Baltimore
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Prebieha náborFáza 2
- University of Maryland Greenebaum Cancer Center, Baltimore
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Prebieha náborFáza 1/2
- Johns Hopkins Hospital, Baltimore
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Prebieha náborFáza 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Prebieha náborFáza 1
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
Prebieha náborObservačná štúdia
- Johns Hopkins University, Baltimore
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
Prebieha náborFáza 2
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prebieha náborFáza 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Prebieha náborFáza 1
- Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore
7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer
Prebieha nábor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
The COSMYC Trial (COmbined Suppression of MYC)
Prebieha náborFáza 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Prebieha náborFáza 1
- Advanced Molecular Imaging and Therapy, Glen Burnie · 9 míľ odtiaľ
- United Theranostics - Chesapeake, Glen Burnie · 9 míľ odtiaľ
TERPS Trial for de Novo Oligometastic Prostate Cancer
Prebieha náborFáza 2
- Maryland Proton Treatment Center, Baltimore
- UMMC, Baltimore
- Baltimore Washington Medical Center, Glen Burnie · 9 míľ odtiaľ
- a 1 ďalších
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Prebieha náborObservačná štúdia
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Clinical Trial of Approaches to Prostate Cancer Surgery
Prebieha nábor
- Johns Hopkins University, Baltimore
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Prebieha náborFáza 2/3
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization
Prebieha náborObservačná štúdia
- Johns Hopkins University, Baltimore
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Prebieha náborFáza 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
Prebieha náborFáza 2
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
Prebieha náborSkorá fáza 1
- SKCCC at Johns Hopkins, Baltimore
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Prebieha náborFáza 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Prebieha náborFáza 1
- Chesapeake Urology, Towson · 8 míľ odtiaľ
Physician- and Patient-based Barriers to NGS Testing
Prebieha nábor
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Prebieha náborFáza 2
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe
Prebieha náborFáza 1
- Johns Hopkins Hospital, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 míľ odtiaľ
Exercise in Prostate Cancer
Prebieha nábor
- Johns Hopkins University, Baltimore
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Prebieha náborFáza 1/2
- Johns Hopkins, Baltimore
Štúdie Rakovina prostaty v iných mestách
- New York City, NY103 štúdií
- Houston, TX76 štúdií
- Los Angeles, CA61 štúdií
- Boston, MA59 štúdií
- St. Louis, MO46 štúdií
- Chicago, IL45 štúdií
- San Francisco, CA45 štúdií
- Philadelphia, PA44 štúdií
- Nashville, TN43 štúdií
- Seattle, WA42 štúdií
- Washington, DC38 štúdií
- Dallas, TX36 štúdií
Iné štúdie v Baltimore
- Nemalobunkový karcinóm pľúc60 štúdií
- Rakovina prsníka47 štúdií
- Rakovina pľúc40 štúdií
- Rakovina (všetky typy)37 štúdií
- Rakovina pankreasu31 štúdií
- Kolorektálny karcinóm31 štúdií
- Metastatická rakovina28 štúdií
- Obézita26 štúdií
- Rakovina močového mechúra24 štúdií
- Srdcové zlyhanie24 štúdií
- Rakovina vaječníkov22 štúdií
- Cievna mozgová príhoda21 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.